FDA NDC Directory · JSON-LD · Markdown

Efavirenz

NDC 65862-105 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA078064
Dosage form / routeCAPSULE · ORAL
Active ingredientsEFAVIRENZ (100 mg/1)
Marketing started20171215
Package count2

External sources

Source: openFDA. Public-domain (CC0).